SITC 2024: Society for Immunotherapy of Cancer Annual Meeting 2024
06 Nov 2024 - 10 Nov 2024Houston, Texas, USA
IVIM Technology
Dear Esteemed Colleagues and Professionals,
Warm greetings from IVIM Technology!
We are thrilled to connect with you as a leading global provider of in vivo intravital microscopy and preclinical imaging solutions.
With the highly anticipated Society for Immunotherapy of Cancer Annual Meeting 2024 (SITC 2024) just around the corner, we are excited to invite you to visit us at Booth 632 in Houston, Texas, from November 6-10.
At IVIM Technology, we are proud to present cutting-edge advancements inin vivo intravital imaging. Our services include intravital microscopy and CRO imaging from our BSL-2 animal facilities in South Korea. Additionally, through our I-VIVA Support Program, you can receive online or offline training for animal handling and IVM imaging. You also have the option to rent our state-of-the-art intravital microscopes or utilize our mouse models directly at our facility.
Anticipation is building, and we are eagerly counting down the days to the commencement of SITC 2024. Looking forward to meeting you in Houston!
Best Regards,
IVIM Technology
Poster Presentation:
Abstract Title: Monitoring the Correlation between Small Molecule Drugs and Immune Cells in Animal Models of Cancer through Intravital Microscopy
Abstract Number: #1308
Session: Saturday, November 9, 2024: 9:00 AM-8:30 PM
Key Points:
Optimizing Small Molecule Drugs: Intravital microscopy (IVM) enables real-time observation of how small molecule drugs interact with immune cells within the tumor microenvironment, providing insights into optimizing drug dosing and timing to enhance immune responses in combination therapies.
Precision Immunotherapy: IVM allows for the direct visualization of drug-immune dynamics at a cellular level, offering the potential to refine immunotherapy approaches by identifying specific immune cell behaviors and drug effects in live tissue, leading to more tailored and effective cancer treatments.
